Search Results - "Öztürk, Mert Burak"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Use of Non-steroidal Anti-inflammatory Drugs for Chemoprevention of Inflammation-induced Prostate Cancer by Debeleç Bütüner, Bilge, Öztürk, Mert Burak

    Published in Turkish journal of pharmaceutical sciences (01-12-2017)
    “…Chronic inflammation has been known as one of the major causes of cancer progression and 25% of cancer cases initiate due to chronic inflammation according to…”
    Get full text
    Journal Article
  2. 2

    Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis by Debeleç-Bütüner, Bilge, Öztürk, Mert Burak, Tağ, Özgür, Akgün, İsmail Hakkı, Yetik-Anacak, Günay, Bedir, Erdal, Korkmaz, Kemal Sami

    Published in Steroids (01-07-2018)
    “…•9,19-cyclolanostane derivatives starting from cycloastragenol were synthesized.•Five analogs were selected to be screened for their anti-inflammatory…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1 by Xu, Xueyong, Li, Yinghui, Bharath, Sakshibeedu R., Ozturk, Mert Burak, Bowler, Matthew W., Loo, Bryan Zong Lin, Tergaonkar, Vinay, Song, Haiwei

    Published in Nature communications (09-08-2018)
    “…Transcriptional factors ETS1/2 and p52 synergize downstream of non-canonical NF-κB signaling to drive reactivation of the −146C>T mutant TERT promoter in…”
    Get full text
    Journal Article
  5. 5

    Current Insights to Regulation and Role of Telomerase in Human Diseases by Ozturk, Mert Burak, Li, Yinghui, Tergaonkar, Vinay

    Published in Antioxidants (28-02-2017)
    “…The telomerase ribonucleoprotein complex has a pivotal role in regulating the proliferation and senescence of normal somatic cells as well as cancer cells…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Genome-wide screens identify specific drivers of mutant hTERT promoters by Shanmugam, Raghuvaran, Ozturk, Mert Burak, Low, Joo-Leng, Akincilar, Semih Can, Chua, Joelle Yi Heng, Thangavelu, Matan Thangavelu, Periyasamy, Giridharan, DasGupta, Ramanuj, Tergaonkar, Vinay

    “…Cancer-specific promoter mutations reported in 19% of cancers result in enhanced telomerase activity. Understanding the distinctions between transcriptional…”
    Get full text
    Journal Article
  8. 8

    Identification of Novel Transcriptional Modulators of Oncogenesis by Ozturk, Mert Burak

    Published 01-01-2019
    “…Oncogenesis is the process by which cells undergo a series of genetic and cellular changes and enable unlimited proliferation. Healthy cells have developed…”
    Get full text
    Dissertation
  9. 9

    HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate by Hamid, Syed Muhammad, Cicek, Seher, Karamil, Selda, Ozturk, Mert Burak, Debelec-Butuner, Bilge, Erbaykent-Tepedelen, Burcu, Varisli, Lokman, Gonen-Korkmaz, Ceren, Yorukoglu, Kutsal, Korkmaz, Kemal Sami

    Published in Molecular and cellular endocrinology (05-03-2014)
    “…•HOXB13 is a homeobox protein that is expressed in normal adult prostate and in cancer.•HOXB13 physically associates with cyclin D1 and cyclin B1.•HOXB13…”
    Get full text
    Journal Article
  10. 10

    Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention by Bilge Debelec-Butuner, Mert Burak Ozturk, Ozgur Tag, Ismail Hakki Akgun, Erdal Bedir, Kemal Sami Korkmaz

    Published in Proceedings (01-11-2017)
    “…Inhibition of inflammation-induced carcinogenesis is an efficient therapeutic strategy for cancer chemoprevention as use of anti-inflammatories was reported to…”
    Get full text
    Journal Article